Should I Take GLP-1? Benefits, Risks & Biomarker Context

Last reviewed: May 30, 2026

Last updated: May 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Whether GLP-1 therapy is right for you depends on metabolic status, medical history, and individual response potential—not a single yes-or-no answer. Recent data shows GLP-1 receptor agonists reduce weight by 15-22% in eligible patients, but baseline biomarkers and genetic factors may influence outcomes.

This decision matters because starting GLP-1 involves commitment to ongoing treatment, potential side effects, and cost. PlexusDx supports precision-wellness decisions by helping you understand your metabolic profile and genetic predispositions before discussing GLP-1 with your provider.

Who Is GLP-1 Therapy Actually Intended For?

GLP-1 receptor agonists are approved or commonly used for adults with obesity (BMI ≥30), overweight with weight-related conditions (BMI ≥27 with hypertension, diabetes, or dyslipidemia), or type 2 diabetes. Not all patients in these categories are ideal candidates.

Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or uncontrolled psychiatric illness. Your provider must assess these factors before initiating therapy.

Metabolic and Biomarker Factors That Inform GLP-1 Suitability

Baseline biomarkers—fasting glucose, HbA1c, lipids, and inflammatory markers—provide context for whether GLP-1 may address your specific metabolic dysfunction. High insulin resistance or baseline inflammation may predict stronger response, though individual variation is significant.

Biomarker	Clinical Significance for GLP-1 Consideration
Fasting Insulin	Elevated levels suggest insulin resistance; GLP-1 may help restore sensitivity
HbA1c (>5.7%)	Indicates prediabetes or diabetes; GLP-1 improves glycemic control
Triglyceride-to-HDL Ratio	High ratio reflects metabolic dysfunction; GLP-1 improves lipid profile
C-Reactive Protein (hsCRP)	Elevated inflammation may correlate with better weight-loss response to GLP-1

Genetic Predispositions and GLP-1 Response Pathways

Your genes influence appetite regulation, energy expenditure, and GLP-1 receptor sensitivity. Variants in GLP1R, GIPR, FTO, and MC4R genes affect how your body processes appetite signals and may provide context for expected response variation.

The Precision Peptide Genetic Test identifies predispositions in these peptide pathways, helping you and your provider understand whether genetic factors may influence your GLP-1 journey. This test does not predict exact medication response but may help contextualize individual variation in outcomes.

Expected Benefits, Side Effects, and Timeline Realities

Clinical trials show GLP-1 agents reduce body weight by 15-22% over 68 weeks, lower HbA1c by 1-2%, and improve cardiovascular outcomes in patients with established heart disease. Benefits emerge gradually over weeks to months, not immediately.

Common side effects—nausea, vomiting, constipation, loss of appetite—typically resolve within 4-8 weeks but persist in some patients. Rare but serious risks include pancreatitis, gallbladder issues, and thyroid concerns. Your provider must monitor for these and adjust dosing accordingly.

How to Evaluate GLP-1 as Your Next Step: A Provider-Centered Framework

Start by asking: Do I meet clinical criteria (BMI, metabolic status, medical history)? Have I tried lifestyle changes for 3-6 months? Do I have contraindications? What is my realistic timeline and financial commitment? Document answers for your provider conversation.

Bring baseline bloodwork, a list of medications and supplements, and a clear weight-loss goal. Discuss side-effect tolerance, injection or oral preference, and monitoring frequency. Your provider may recommend biomarker testing or genetic context (via Precision Peptide Genetic Test) before starting to tailor expectations.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context for how genetic variants in GLP1R, GIPR, FTO, and MC4R pathways influence your appetite regulation and metabolic response. This information should be interpreted with a qualified healthcare provider as one component of your overall assessment—not as a definitive predictor of GLP-1 success.

The genetic test reveals predispositions in peptide signaling pathways that regulate hunger, fullness, and energy expenditure. For example, certain FTO variants correlate with higher baseline appetite; GIPR variants may influence glucose-dependent insulinotropic peptide sensitivity. Understanding your genetic profile may help you and your provider set realistic expectations and choose between different GLP-1 compounds or dosing strategies.

Combined with biomarker assessment (fasting insulin, HbA1c, lipids), genetic context can support a more personalized conversation about whether GLP-1 aligns with your metabolic needs and whether compounded or alternative formulations might suit your situation better. PlexusDx compounded options range from $129–$309/month depending on formulation, making precision-informed treatment accessible.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $229-$509/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.